Cargando…

Further suggestions on the group-theoretical approach using clinical values

BACKGROUND: In a previous report, we suggested a prototypal model to describe patient states in a graded vector-like format based on the modulo groups via the psychiatric rating scale. In this article, using other simple examples, we provide additional suggestions to clarify how other clinical data...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawamura, Jitsuki, Morishita, Shigeru, Ishigooka, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586959/
https://www.ncbi.nlm.nih.gov/pubmed/23249607
http://dx.doi.org/10.1186/1742-4682-9-54
_version_ 1782261380572774400
author Sawamura, Jitsuki
Morishita, Shigeru
Ishigooka, Jun
author_facet Sawamura, Jitsuki
Morishita, Shigeru
Ishigooka, Jun
author_sort Sawamura, Jitsuki
collection PubMed
description BACKGROUND: In a previous report, we suggested a prototypal model to describe patient states in a graded vector-like format based on the modulo groups via the psychiatric rating scale. In this article, using other simple examples, we provide additional suggestions to clarify how other clinical data can be treated practically in line with our proposed model. METHODS: As illustrations of the wider applicability, we treat four cases commensurate with modulo arithmetic: 1) prescription doses of three medicines (lithium carbonate, mirtazapine, and nitrazepam), 2) changes in laboratory data (blood concentrations of lithium carbonate, white blood cells, percutaneous oxygen saturation and systolic blood pressure), 3) the tumor node metastasis (TNM) classification of malignant tumors applied for esophageal tumors, and 4) the coding schemes of the International Classification of Diseases (ICD) for selected diseases or laboratory data. For each case, we present simple examples in the form of product of states to illustrate these results. RESULTS: 1) Medications and their changes can be represented as elements of a modulo group; e.g., group S = {S(j) | S(j) ∈ Z(13)×Z(4)×Z(3)} can represent the set of all possible prescription combinations of three specified medicines. Likewise, 2) clinical values can also be expressed as a modulo group; e.g., group T = {T(j) | T(j) ∈ Z(600)×Z(50000)×Z(100)×Z(300)} representing the set of all possible data based on any number of clinical values and their differences. Also, 3) the TNM classification for malignant tumors can be treated within a single modulo group C = {C(j) | C(j) ∈ Z(8)×Z(4)×Z(2)×Z(2)}, the set of all composable disease states graded in terms of tumor expansion. Finally, 4) ICD coding schemes provide several examples treatable as a modulo group D = {D(j) | D(j) ∈ Z(7)×Z(7)× …×Z(7) (an n-fold product)}, constituting the set of all possible severities of diseases states and laboratory data within provided tuples. CONCLUSIONS: Despite the limited scope of our methodology, there are grounds where other clinical quantities (prescription of medicine, laboratory data, TNM classification of malignant tumors, and ICD coding schemes) can be also treatable with the same group-theory approach as was suggested for psychiatric disease states in our previous report.
format Online
Article
Text
id pubmed-3586959
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35869592013-03-08 Further suggestions on the group-theoretical approach using clinical values Sawamura, Jitsuki Morishita, Shigeru Ishigooka, Jun Theor Biol Med Model Commentary BACKGROUND: In a previous report, we suggested a prototypal model to describe patient states in a graded vector-like format based on the modulo groups via the psychiatric rating scale. In this article, using other simple examples, we provide additional suggestions to clarify how other clinical data can be treated practically in line with our proposed model. METHODS: As illustrations of the wider applicability, we treat four cases commensurate with modulo arithmetic: 1) prescription doses of three medicines (lithium carbonate, mirtazapine, and nitrazepam), 2) changes in laboratory data (blood concentrations of lithium carbonate, white blood cells, percutaneous oxygen saturation and systolic blood pressure), 3) the tumor node metastasis (TNM) classification of malignant tumors applied for esophageal tumors, and 4) the coding schemes of the International Classification of Diseases (ICD) for selected diseases or laboratory data. For each case, we present simple examples in the form of product of states to illustrate these results. RESULTS: 1) Medications and their changes can be represented as elements of a modulo group; e.g., group S = {S(j) | S(j) ∈ Z(13)×Z(4)×Z(3)} can represent the set of all possible prescription combinations of three specified medicines. Likewise, 2) clinical values can also be expressed as a modulo group; e.g., group T = {T(j) | T(j) ∈ Z(600)×Z(50000)×Z(100)×Z(300)} representing the set of all possible data based on any number of clinical values and their differences. Also, 3) the TNM classification for malignant tumors can be treated within a single modulo group C = {C(j) | C(j) ∈ Z(8)×Z(4)×Z(2)×Z(2)}, the set of all composable disease states graded in terms of tumor expansion. Finally, 4) ICD coding schemes provide several examples treatable as a modulo group D = {D(j) | D(j) ∈ Z(7)×Z(7)× …×Z(7) (an n-fold product)}, constituting the set of all possible severities of diseases states and laboratory data within provided tuples. CONCLUSIONS: Despite the limited scope of our methodology, there are grounds where other clinical quantities (prescription of medicine, laboratory data, TNM classification of malignant tumors, and ICD coding schemes) can be also treatable with the same group-theory approach as was suggested for psychiatric disease states in our previous report. BioMed Central 2012-12-19 /pmc/articles/PMC3586959/ /pubmed/23249607 http://dx.doi.org/10.1186/1742-4682-9-54 Text en Copyright ©2012 Sawamura et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Sawamura, Jitsuki
Morishita, Shigeru
Ishigooka, Jun
Further suggestions on the group-theoretical approach using clinical values
title Further suggestions on the group-theoretical approach using clinical values
title_full Further suggestions on the group-theoretical approach using clinical values
title_fullStr Further suggestions on the group-theoretical approach using clinical values
title_full_unstemmed Further suggestions on the group-theoretical approach using clinical values
title_short Further suggestions on the group-theoretical approach using clinical values
title_sort further suggestions on the group-theoretical approach using clinical values
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586959/
https://www.ncbi.nlm.nih.gov/pubmed/23249607
http://dx.doi.org/10.1186/1742-4682-9-54
work_keys_str_mv AT sawamurajitsuki furthersuggestionsonthegrouptheoreticalapproachusingclinicalvalues
AT morishitashigeru furthersuggestionsonthegrouptheoreticalapproachusingclinicalvalues
AT ishigookajun furthersuggestionsonthegrouptheoreticalapproachusingclinicalvalues